|
Gynecare Thermachoice Long term clinical data show Proven efficiency and patient satisfaction
- 95.1% success rate (return to normal bleeding or less) among patients treated at 5 years
- 73.7% of patients treated report decreased dymenorrhea at 3 years
- 64% of patients report none to mild premenstrual symptoms at 3 years
- 93% of patients ablation system with experience in over 325,000 patients worldwide
Designed for Safety
- No incision made
- Perforation detection system that operates prior to and during the procedure.
- Silicone balloon
- Latex free
- Softly conforms to the contours of a woman's uterus
- Rate of reported complications is only 0.31 per 1000 cases- lowest of all FDA- approved endometrial ablation technologies as of May, 2003
- Hormone free
- Definite
- Hormone free
- Minimally Invasive
|
|
Gynecare Thermachoice
|
Hormone Therapy
|
D & C
|
Hysterectomy
|
|
Definitive treatment for the majority of women
|
Yes
|
|
|
Yes
|
|
Minimally invasive
|
Yes
|
Yes
|
Yes
|
|
|
Hormone free
|
Yes
|
|
Yes
|
Yes
|
|
No overnight stary required
|
Yes
|
Yes
|
Yes
|
|
|
Most patients return to normal activity within 1 week
|
Yes
|
Yes
|
Yes
|
|
|
